insights_auto
Why is YPSN down 2.15%?
Dive Deeperchevron_right
YPSN:SWX
Ypsomed Holding AG
CHF 355.40
arrow_downward
-2.15%(-7.80) 1D
Oct 8, 5:30:32 PM GMT+2 · CHF
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for YPSN...
Open
CHF 360.40
High
CHF 361.00
Low
CHF 353.60
Mkt. cap
4.57B
Avg. vol.
17.05K
Volume
0.00
Dividend
1.24%
Quarterly dividend
CHF 1.10
Ex-dividend date
Jul 3, 2026
P/E ratio
21.79
52-wk high
CHF 418.00
52-wk low
CHF 260.50
EPS
CHF 16.31
Shares outstanding
13.15M
No. of employees
2K
Open
CHF 360.40
High
CHF 361.00
Low
CHF 353.60
Mkt. cap
4.57B
Avg. vol.
17.05K
Volume
0.00
Dividend
1.24%
Quarterly dividend
CHF 1.10
Ex-dividend date
Jul 3, 2026
P/E ratio
21.79
52-wk high
CHF 418.00
52-wk low
CHF 260.50
EPS
CHF 16.31
Shares outstanding
13.15M
No. of employees
2K
News stories
From web sources and news partners
Renaissance Capital
·
1 hour ago
Metal powder producer Amaero revives Nasdaq listing plans, slashing deal size by about 60% ahead of $20 million IPO
Simply Wall Street
·
33 minutes ago
Does AST SpaceMobile (ASTS) Canada Test Change The Direct To Device Story?
Investor's Business Daily
·
1 hour ago
Futures: AI Stocks Skid On OpenAI; SpaceX Move Hits Telecom Rivals
Profile
Ypsomed Holding Inc. is a Swiss multinational medical technology company headquartered in Burgdorf, Switzerland. Founded in 2003, through the break up of Disetronic Group, founded by Willy Michel. Ypsomed specializes in developing and manufacturing injection and infusion systems for self-medication, primarily in the areas of diabetes care and biotechnology.
Products include devices like insulin pens, auto-injectors, and infusion pumps, which help patients manage chronic conditions more easily and independently. In 2025, Ypsomed employs 2,800+ employees and has an annual turnover of 728.9 million Swiss Francs. The company is listed on SIX Swiss Exchange. Wikipedia
About Ypsomed Holding AG